Les Sulewski's Stock Ratings

Truist Securities Analyst

Les Sulewski is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

-13.6%

Smart Score

40.1%

Overall Average Return Percentile

14th

Number of Ratings

14
Buy NowGet Alert
11/07/2025PCRXBuy Now
Pacira BioSciences
$26.943.93%$30 → $28MaintainsBuyGet Alert
11/07/2025COLLBuy Now
Collegium Pharmaceutical
$48.59-1.22%$45 → $48MaintainsBuyGet Alert
05/28/2025TEVABuy Now
Teva Pharmaceutical Indus
$30.09-16.9% → $25Initiates → BuyGet Alert
01/30/2025PCRXBuy Now
Pacira BioSciences
$26.94-7.2%$8 → $25UpgradeSell → HoldGet Alert
10/02/2024AMRXBuy Now
Amneal Pharmaceuticals
$12.26-2.08%$10 → $12MaintainsBuyGet Alert
08/13/2024PCRXBuy Now
Pacira BioSciences
$26.94-70.3%$30 → $8DowngradeBuy → SellGet Alert
08/12/2024AMRXBuy Now
Amneal Pharmaceuticals
$12.26-18.4%$9 → $10MaintainsBuyGet Alert
08/09/2024COLLBuy Now
Collegium Pharmaceutical
$48.59-13.57%$40 → $42MaintainsBuyGet Alert
07/25/2024PCRXBuy Now
Pacira BioSciences
$26.9411.36%$45 → $30MaintainsBuyGet Alert
07/02/2024PCRXBuy Now
Pacira BioSciences
$26.9467.04%$45 → $45ReiteratesBuy → BuyGet Alert
05/06/2024AMRXBuy Now
Amneal Pharmaceuticals
$12.26-26.56%$7 → $9ReiteratesBuy → BuyGet Alert
02/26/2024COLLBuy Now
Collegium Pharmaceutical
$48.59-17.69%$37 → $40MaintainsBuyGet Alert
11/02/2023PCRXBuy Now
Pacira BioSciences
$26.9467.04%$50 → $45MaintainsBuyGet Alert
08/03/2023PCRXBuy Now
Pacira BioSciences
$26.94104.16%$60 → $55MaintainsBuyGet Alert